{{--
 
--}}
{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode'])) Logout @endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
Back

A survey to understand usage pattern of FDC Pregabalin, Nortriptyline and Methylcobalamin for the treatment of diabetic neuropathic pain with coexisting B12 deficiency in India.

Survey Questionnaire Form
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif
{{--

--}}

Questionnaire

  1. How many patients of Neuropathic pain do you see in a month? *

  2. From your clinical experience, mention the most common type of Neuropathic pain patients that present to you at diagnosis? *

  3. In your experience, how many patients with diabetic neuropathy have coexisting B12 deficiency? *

  4. Do you consider pregabalin as a first-line treatment for neuropathy? *

  5. What percentage of your neuropathy patients achieve satisfactory symptom relief with pregabalin alone? *

  6. In your practice, what proportion of neuropathy patients require combination therapy involving pregabalin? *

  7. What percentage of your neuropathy patients are currently prescribed FDC of pregabalin, nortriptyline and methylcobalamin treatment? *

  8. In your experience, how effective do you find FDC of pregabalin, nortriptyline and methylcobalamin in managing diabetic neuropathy symptoms? *
  9. On a scale of 1 to 5, How satisfied are you with the current dosing options available for FDC of pregabalin, nortriptyline and methylcobalamin? (5 being very satisfied) *

  10. In your experience, how quickly do patients typically respond to FDC of pregabalin, nortriptyline and methylcobalamin treatment? *

  11. Which factors are critical for choosing FDC of pregabalin, nortriptyline and methylcobalamin in diabetic neuropathic pain? *
  12. On average, how long do your patients remain on FDC of pregabalin, nortriptyline and methylcobalamin treatment? *

  13. Do you prefer prescribing the fixed dose combination over giving pregabalin, nortriptyline and methylcobalamin separately? If no, please specify reason. *

  14. In your experience, does FDC of pregabalin, nortriptyline and methylcobalamin provide long-term benefits for peripheral neuropathy patients? *

  15. Have you observed any differences in treatment response based on patient’s age when prescribing FDC of pregabalin, nortriptyline and methylcobalamin in diabetic neuropathy patients? *

  16. Have you observed any differences in treatment response based on patient’s gender when prescribing FDC of pregabalin, nortriptyline and methylcobalamin in diabetic peripheral neuropathy patients? *

  17. What percentage of your patients report satisfactory compliance with FDC of pregabalin, nortriptyline and methylcobalamin treatment? *

  18. How satisfied are your patients with the response of the FDC of pregabalin, nortriptyline and methylcobalamin in managing their diabetic peripheral neuropathic pain? (5 being very satisfied) *

  19. How satisfied are your patients with the tolerability of the FDC of pregabalin, nortriptyline and methylcobalamin in managing their diabetic peripheral neuropathic pain? (5 being very satisfied) *

  20. Do you find FDC of pregabalin, nortriptyline and methylcobalamin more effective than other medications commonly prescribed for diabetic neuropathy? *

  21. What percentage of adults exhibit satisfactory tolerance FDC of pregabalin, nortriptyline and methylcobalamin? *

  22. How do you assess the long-term efficacy of the FDC of pregabalin, nortriptyline and methylcobalamin in managing diabetic neuropathic pain? *
  23. What percentage of your neuropathy patients experience significant improvement in sleep quality with FDC of pregabalin, nortriptyline and methylcobalamin? *

  24. How frequently do you encounter patients who discontinue FDC of pregabalin, nortriptyline and methylcobalamin due to lack of efficacy? *

  25. In your experience, do patients with neuropathic pain having comorbidities influence your decision to prescribe FDC of pregabalin, nortriptyline and methylcobalamin and Why? *
  26. Based on your experience, do you think additional research is needed to better understand FDC of pregabalin, nortriptyline and methylcobalamin in diabetic neuropathy management? *

  27. In your opinion, what advantage does FDC of pregabalin, nortriptyline and methylcobalamin offer over other combinations in diabetic neuropathy management? *
  28. How would you rate your overall experience with prescribing FDC of pregabalin, nortriptyline and methylcobalamin in diabetic neuropathy management? (5 being very satisfied) *

  29. How do you adjust the treatment plan based on the disease progression? *